From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review.

Authors:
Regmi M; Wang Y; Liu W; Dai Y; Liu S and 6 more

Journal:
J Exp Clin Cancer Res

Publication Year: 2024

DOI:
10.1186/s13046-024-02973-5

PMCID:
PMC10860318

PMID:
38342925

Journal Information

Full Title: J Exp Clin Cancer Res

Abbreviation: J Exp Clin Cancer Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (82371319 to CY), Beijing Nova Program (20230484356 to CY), Beijing Natural Science Foundation (7222217 to CY), Capital Health Research and Development of Special (2022–4-40918 to CY), AO Spine Research Start-up Grant (AOS-Startup-21–016 to CY), Peking University Clinical Medicine Plus X-Young Scholars Project (PKU2021LCXQ007 to CY), and Peking University Third Hospital Clinical Key Project (BYSYZD2021023 to CY)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025